Hydroxyprogesterone (Hydroxyprogesterone Caproate Injection USP) Injection 250mg

Description

Hydroxyprogesterone Caproate Injection USP 250mg is a synthetic progestogen administered intramuscularly to reduce the risk of preterm birth in pregnant women with a singleton pregnancy who have a history of spontaneous preterm delivery. It works by mimicking the natural hormone progesterone, helping to maintain uterine quiescence by reducing uterine contractility and supporting the integrity of the cervix, thereby prolonging pregnancy to term. Administered as a weekly intramuscular injection typically starting between 16 to 20 weeks of gestation and continuing until 37 weeks, it is an important prophylactic measure in high-risk pregnancies. It is also used in gynecological conditions such as amenorrhea, abnormal uterine bleeding, and endometrial carcinoma, making it a versatile hormonal preparation in both obstetric and gynecological practice.